These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 27164496)
1. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496 [TBL] [Abstract][Full Text] [Related]
2. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
3. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805 [TBL] [Abstract][Full Text] [Related]
4. Topical Sustained-Release Dexamethasone-Loaded Chitosan Nanoparticles: Assessment of Drug Delivery Efficiency in a Rabbit Model of Endotoxin-Induced Uveitis. Alkholief M; Kalam MA; Raish M; Ansari MA; Alsaleh NB; Almomen A; Ali R; Alshamsan A Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765242 [TBL] [Abstract][Full Text] [Related]
5. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma. Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821 [TBL] [Abstract][Full Text] [Related]
6. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes. Kalam MA; Alshamsan A Biomed Pharmacother; 2017 Oct; 94():402-411. PubMed ID: 28772219 [TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery. Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107 [TBL] [Abstract][Full Text] [Related]
9. Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. Ban J; Zhang Y; Huang X; Deng G; Hou D; Chen Y; Lu Z Int J Nanomedicine; 2017; 12():1329-1339. PubMed ID: 28243093 [TBL] [Abstract][Full Text] [Related]
10. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263 [TBL] [Abstract][Full Text] [Related]
11. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. Wadhwa S; Paliwal R; Paliwal SR; Vyas SP J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753 [TBL] [Abstract][Full Text] [Related]
13. Chitosan based nanocarriers for indomethacin ocular delivery. Badawi AA; El-Laithy HM; El Qidra RK; El Mofty H; El dally M Arch Pharm Res; 2008 Aug; 31(8):1040-9. PubMed ID: 18787795 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate. Behl G; Iqbal J; O'Reilly NJ; McLoughlin P; Fitzhenry L Pharm Res; 2016 Jul; 33(7):1638-48. PubMed ID: 26964548 [TBL] [Abstract][Full Text] [Related]
15. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Nagarwal RC; Kumar R; Pandit JK Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098 [TBL] [Abstract][Full Text] [Related]
16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
17. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution. Liu D; Li J; Cheng B; Wu Q; Pan H Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726 [TBL] [Abstract][Full Text] [Related]
18. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery. Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride. Liu D; Lian Y; Fang Q; Liu L; Zhang J; Li J Int J Biol Macromol; 2018 Sep; 116():1026-1036. PubMed ID: 29778883 [TBL] [Abstract][Full Text] [Related]
20. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery. Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]